NEWS: COVID-19 VACCINE RECEIVES HEALTH CANADA APPROVAL (DEC 2020)
The BioNTech (with Pfizer) COVID-19 vaccine that uses our lipid nanoparticle delivery system technology has received emergency use authorization by Health Canada. Read about it here.
MEDIA COVERAGE: BIOPHARM INTERNATIONAL (JUN 2021)
Learn more about our proprietary lipid nanoparticle delivery system technology used in the BioNTech/Pfizer COVID-19 vaccine in this BioPharm International article. Read about it here.
NEWS: ACUITAS ANNOUNCES PUBLICATION OF RESEARCH IN NATURE (MAY 2021)
Acuitas Therapeutics announced publication of research results in the prestigious journal Nature, from the company’s work as part of a collaboration with Verve Therapeutics, Inc. Read about it here.